Complete Medical Billing Services for ID Practices

Complete medical billing services for infectious disease practices can cover the revenue cycle from charge entry and coding review through claim submission, rejection clearing, payment reconciliation, denial appeals, and accounts receivable follow-up. Specialized support may also address eligibility, prior authorization, drug and infusion billing, payer contracts, and workflow improvement so the practice can evaluate how clinical services translate into reimbursement.

Infectious disease practices may combine cognitive visits and consultations with infusion, OPAT, specialty drugs, drug acquisition, and different benefit structures. Billing workflows therefore need to connect documentation, coding, authorization, drug and administration charges, payer rules, and collections. A practice may also need to review hospital coverage or stewardship agreements when important clinical work is delivered without a straightforward billing pathway.

Support can include E/M claims, hospital consult claims, infusion claims, and drug claims, depending on the practice’s services and workflow. Common activities include charge entry, coding review, claim scrubbing, submission, rejection clearing, payment reconciliation, denial management, and aging claims follow-up. The relevant mix should reflect the practice’s actual service lines rather than generalized assumptions.

Yes. Authorization support may include verifying eligibility and benefits, determining whether therapy falls under the medical or pharmacy benefit, and managing prior authorizations for infusions, OPAT courses, and specialty drugs. Tracking each request helps the practice maintain visibility into authorization status and reduce the risk of providing therapy without a clear reimbursement pathway.

Denial management begins by grouping denials according to their root causes, such as drug and administration coding, missing authorization, medical versus pharmacy benefit confusion, or incomplete consult documentation. Payer-specific appeals can then be prepared with supporting clinical documentation. Findings should also be shared with clinical, coding, and front-office teams so recurring issues are addressed upstream.

Payment reconciliation compares payer payments with expected reimbursement for drug, administration, and E/M claims. The review can identify short-pays, incorrect fee schedule application, and unit or NDC mismatches. Underpayments may then be disputed and tracked through recovery. The exact review depends on the practice’s contracts, claims, payment records, and available documentation.

Yes. GrowInfectiousDisease emphasizes applying a practice’s own figures rather than relying on generalized rates or margins. Users can examine their service mix, operational choices, reimbursement information, and revenue-cycle patterns using transparent guidance and browser-based tools. This approach helps preserve the distinction between information that is verified and results that are specific to the individual practice.

GrowInfectiousDisease provides free, ungated resources and calculators focused on infectious disease practice economics. No email submission is required to receive a result, and calculator tools run in the browser without transmitting or storing user-entered data. The resource does not publish invented rates, benchmarks, drug acquisition costs, payment rates, or margin figures.